Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia

NCT03055624 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT03055624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03055624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Lead sponsor
University of California, San Diego
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2017
Completion date
February 18, 2019
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enlarged prostate with lower urinary tract symptoms, prostatic hyperplasia, benign